Crisis Management & Strategic Response

Experience Highlights

• Diverse clients in their responses to an array of COVID-19 issues impacting their businesses, including financial hardships for debtors and creditors, liabilities and immunities, allegations of employee negligence, supply chain disruptions, class actions, compliance with government contracting requirements, and data privacy concerns.

• ​​​​​BP as lead environmental counsel, in responding to the Deepwater Horizon oil rig explosion and its aftermath, including negotiating the historic settlement of all federal and state environmental claims. 

• Wanaque Center for Nursing and Rehabilitation in its response to a deadly viral outbreak by conducting an independent investigation of the facility's response; responding to investigations, reviews, and enforcement action by multiple law enforcement and regulatory agencies; representing the facility in ongoing litigation with the Centers for Medicare and Medicaid Services; and coordinating the overall response to the media and the state legislature.

• Carnival Corporation, as lead counsel for the defendants, in securing dismissal of all U.S. claims and appeals across the country arising from the widely publicized shipwreck involving the Costa Crociere cruise ship Costa Concordia. 

• Newark Beth Israel Medical Center and its parent RWJBarnabas Health in conducting an independent investigation, responding to multiple enforcement investigations and regulatory reviews, and overseeing the response to extensive media scrutiny and congressional and legislative inquiries following allegations in the national press that patient care in the hospital’s heart transplant program was compromised to improve survival statistics.

• General Electric in securing dismissal of putative class action alleging personal injuries from radiation exposure arising out of the Fukushima nuclear power plant meltdown.

• ​​​​​​News Corporation's Management and Standards Committee in relation to the investigations involving voicemail interception and payments to public officials, which included advising on all concurrent proceedings. Successfully defended the company in relation to all allegations of alleged wrongdoing.

• Pharmaceutical company in a large-scale, multiyear off-label promotion investigation by DOJ, FDA and the New Jersey U.S. Attorney’s Office, and in a publicly filed First Amendment and statutory challenge to FDA's intended-use regulations in federal court in Washington, D.C. The matter involved parallel criminal, civil and administrative investigations.